{"transactions":[{"id":1127276,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-02T20:01:35.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025."}],"balance_after":28000,"derivative":{"exercise_price":0.688,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001213900-25-050020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025050020/ownership.xml","form_type":"4"}},{"id":1559271,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-27T22:21:27.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024."}],"balance_after":12000,"derivative":{"exercise_price":1.35,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001213900-24-026724","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390024026724/ownership.xml","form_type":"4"}},{"id":1877721,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-25T20:43:30.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023."}],"balance_after":50000,"derivative":{"exercise_price":0.3025,"exercise_date":"2023-05-23","expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-23-043121","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390023043121/ownership.xml","form_type":"4"}},{"id":2371506,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-02-25T19:57:59.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022."}],"balance_after":40000,"derivative":{"exercise_price":2,"exercise_date":"2022-03-23","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-22-009425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390022009425/ownership.xml","form_type":"4"}},{"id":2453743,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-03T15:39:28.000Z","date":"2021-12-30","kind":"purchase","acquired":true,"shares":10000,"price":2.71,"value":27100.0,"ownership":{"direct":false,"nature":"Roth IRA FBO James W Newman, Jr."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transaction at prices ranging from $2.655 to $2.72, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Courtney Newman is the daughter of James W. Newman, Jr."}],"balance_after":34644,"source":{"system":"sec-edgar","filing":"0001213900-22-000067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390022000067/ownership.xml","form_type":"4"}},{"id":2453742,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-03T15:39:28.000Z","date":"2021-12-30","kind":"purchase","acquired":true,"shares":5000,"price":2.72,"value":13600.0,"ownership":{"direct":false,"nature":"Ivy Cottage Group, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"James W. Newman is the general partner of Ivy Cottage Group, LLC."}],"balance_after":50221,"source":{"system":"sec-edgar","filing":"0001213900-22-000067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390022000067/ownership.xml","form_type":"4"}},{"id":2453741,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-03T15:39:28.000Z","date":"2021-12-30","kind":"purchase","acquired":true,"shares":10000,"price":2.66,"value":26600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transaction at prices ranging from $2.628 to $2.68, inclusive. The reporting person undertakes to provide Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (6) of this Form 4."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001213900-22-000067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390022000067/ownership.xml","form_type":"4"}},{"id":2491853,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T14:25:43.000Z","date":"2021-11-26","kind":"purchase","acquired":true,"shares":10000,"price":2.85,"value":28500.0,"ownership":{"direct":false,"nature":"Rountop Limited Partnership, LLP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"James W. Newman, Jr. is the general partner of Roundtop Limited Partnership, LLP."}],"balance_after":34475,"source":{"system":"sec-edgar","filing":"0001213900-21-062465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390021062465/ownership.xml","form_type":"4"}},{"id":2868633,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-02-10T22:54:10.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."}],"balance_after":40000,"derivative":{"exercise_price":3.11,"exercise_date":"2021-03-08","expiration_date":"2031-02-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-21-008165","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390021008165/ownership.xml","form_type":"4"}},{"id":2891890,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-29T00:44:25.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":2544,"ownership":{"direct":false,"nature":"Virga Ventures, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired an aggregate of 3,731 shares of issuer common stock in exchange for an aggregate 0.53% interest in Purnovate, LLC (\"Purnovate\") pursuant to Purnovate's merger into a wholly owned subsidiary of the issuer, as contemplated by that certain Equity Purchase Agreement, dated December 7, 2020, as amended. The shares issued to the reporting person in the merger are currently being held in escrow and 70% of the shares are subject to forfeiture during a one year period following the merger to satisfy claims arising as a result of Purnovate's breach of any of its representations and warranties or covenants in the purchase agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James W. Newman is the sole member of Virga Ventures, LLC."}],"balance_after":152963,"source":{"system":"sec-edgar","filing":"0001213900-21-005041","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390021005041/ownership.xml","form_type":"4"}},{"id":2891889,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-29T00:44:25.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":1187,"ownership":{"direct":false,"nature":"Roundtop Limited Partnership, LLP"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person acquired an aggregate of 3,731 shares of issuer common stock in exchange for an aggregate 0.53% interest in Purnovate, LLC (\"Purnovate\") pursuant to Purnovate's merger into a wholly owned subsidiary of the issuer, as contemplated by that certain Equity Purchase Agreement, dated December 7, 2020, as amended. The shares issued to the reporting person in the merger are currently being held in escrow and 70% of the shares are subject to forfeiture during a one year period following the merger to satisfy claims arising as a result of Purnovate's breach of any of its representations and warranties or covenants in the purchase agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired an aggregate of 3,731 shares of issuer common stock in exchange for an aggregate 0.53% interest in Purnovate, LLC (\"Purnovate\") pursuant to Purnovate's merger into a wholly owned subsidiary of the issuer, as contemplated by that certain Equity Purchase Agreement, dated December 7, 2020, as amended. The shares issued to the reporting person in the merger are currently being held in escrow and 70% of the shares are subject to forfeiture during a one year period following the merger to satisfy claims arising as a result of Purnovate's breach of any of its representations and warranties or covenants in the purchase agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James W. Newman is the general partner of Roundtop Limited Partnership, LLP."}],"balance_after":14475,"source":{"system":"sec-edgar","filing":"0001213900-21-005041","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390021005041/ownership.xml","form_type":"4"}},{"id":3191947,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-30T13:23:54.000Z","date":"2020-03-27","kind":"purchase","acquired":true,"shares":4644,"price":1.35,"value":6269.4,"ownership":{"direct":false,"nature":"Roth IRA FBO James W Newman, Jr."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"James W. Newman is the beneficiary of this Roth IRA."}],"balance_after":14644,"source":{"system":"sec-edgar","filing":"0001213900-20-007845","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390020007845/ownership.xml","form_type":"4"}},{"id":3191946,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-30T13:23:54.000Z","date":"2020-03-27","kind":"purchase","acquired":true,"shares":10000,"price":1.34,"value":13400.0,"ownership":{"direct":false,"nature":"Roundtop Limited Partnership, LLP"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"James W. Newman is the general partner of Roundtop Limited Partnership, LLP."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"James W. Newman is the general partner of Roundtop Limited Partnership, LLP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"James W. Newman is the general partner of Roundtop Limited Partnership, LLP."}],"balance_after":13288,"source":{"system":"sec-edgar","filing":"0001213900-20-007845","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390020007845/ownership.xml","form_type":"4"}},{"id":3191945,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-30T13:23:54.000Z","date":"2020-03-27","kind":"purchase","acquired":true,"shares":5000,"price":1.42,"value":7100.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001213900-20-007845","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390020007845/ownership.xml","form_type":"4"}},{"id":3224204,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-03-06T00:19:14.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."}],"balance_after":60000,"derivative":{"exercise_price":1.44,"exercise_date":"2020-04-03","expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001213900-20-005541","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390020005541/ownership.xml","form_type":"4"}},{"id":3766315,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-11-13T23:47:04.000Z","date":"2018-11-12","kind":"other","acquired":true,"shares":92000,"ownership":{"direct":false,"nature":"Owned by Virga Ventures LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On November 12, 2018, Virga Ventures, LLC exchanged a warrant to purchase 92,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 92,000 shares of common stock. Mr. Newman is the sole member of Virga Ventures, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 12, 2018, Virga Ventures, LLC exchanged a warrant to purchase 92,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 92,000 shares of common stock. Mr. Newman is the sole member of Virga Ventures, LLC."}],"balance_after":92000,"derivative":{"exercise_price":6.25,"exercise_date":"2018-11-12","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001213900-18-015554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018015554/ownership.xml","form_type":"4"}},{"id":3766314,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-11-13T23:47:04.000Z","date":"2018-11-12","kind":"other","acquired":true,"shares":92000,"ownership":{"direct":false,"nature":"Owned by Virga Ventures LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On November 12, 2018, Virga Ventures, LLC exchanged a warrant to purchase 92,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 92,000 shares of common stock. Mr. Newman is the sole member of Virga Ventures, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 12, 2018, Virga Ventures, LLC exchanged a warrant to purchase 92,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 92,000 shares of common stock. Mr. Newman is the sole member of Virga Ventures, LLC."}],"balance_after":92000,"derivative":{"exercise_price":5,"exercise_date":"2018-11-12","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001213900-18-015554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018015554/ownership.xml","form_type":"4"}},{"id":3766313,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase units","published_at":"2018-11-13T23:47:04.000Z","date":"2018-11-12","kind":"other","acquired":false,"shares":92000,"ownership":{"direct":false,"nature":"Owned by Virga Ventures LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On November 12, 2018, Virga Ventures, LLC exchanged a warrant to purchase 92,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 92,000 shares of common stock. Mr. Newman is the sole member of Virga Ventures, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 12, 2018, Virga Ventures, LLC exchanged a warrant to purchase 92,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 92,000 shares of common stock. Mr. Newman is the sole member of Virga Ventures, LLC."}],"balance_after":0,"derivative":{"exercise_price":5,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Units","underlying_shares":184000},"source":{"system":"sec-edgar","filing":"0001213900-18-015554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018015554/ownership.xml","form_type":"4"}},{"id":3766312,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-11-13T23:47:04.000Z","date":"2018-11-12","kind":"other","acquired":true,"shares":20000,"ownership":{"direct":false,"nature":"Ivy Cottage Group, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 12, 2018, Ivy Cottage Group, LLC exchanged a warrant to purchase 20,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 20,000 shares of common stock. Mr. Newman is the general partner of Ivy Cottage Group, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 12, 2018, Ivy Cottage Group, LLC exchanged a warrant to purchase 20,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 20,000 shares of common stock. Mr. Newman is the general partner of Ivy Cottage Group, LLC."}],"balance_after":20000,"derivative":{"exercise_price":6.25,"exercise_date":"2018-11-12","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-18-015554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018015554/ownership.xml","form_type":"4"}},{"id":3766311,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-11-13T23:47:04.000Z","date":"2018-11-12","kind":"other","acquired":true,"shares":20000,"ownership":{"direct":false,"nature":"Ivy Cottage Group, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 12, 2018, Ivy Cottage Group, LLC exchanged a warrant to purchase 20,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 20,000 shares of common stock. Mr. Newman is the general partner of Ivy Cottage Group, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 12, 2018, Ivy Cottage Group, LLC exchanged a warrant to purchase 20,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 20,000 shares of common stock. Mr. Newman is the general partner of Ivy Cottage Group, LLC."}],"balance_after":20000,"derivative":{"exercise_price":5,"exercise_date":"2018-11-12","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-18-015554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018015554/ownership.xml","form_type":"4"}},{"id":3766310,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase units","published_at":"2018-11-13T23:47:04.000Z","date":"2018-11-12","kind":"other","acquired":false,"shares":20000,"ownership":{"direct":false,"nature":"Ivy Cottage Group, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 12, 2018, Ivy Cottage Group, LLC exchanged a warrant to purchase 20,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 20,000 shares of common stock. Mr. Newman is the general partner of Ivy Cottage Group, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 12, 2018, Ivy Cottage Group, LLC exchanged a warrant to purchase 20,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 20,000 shares of common stock. Mr. Newman is the general partner of Ivy Cottage Group, LLC."}],"balance_after":0,"derivative":{"exercise_price":5,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Units","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-18-015554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018015554/ownership.xml","form_type":"4"}},{"id":3854718,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F13","text":"On July 31, 2018, James W. Newman Jr. Roth IRA purchased 10,000 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"On July 31, 2018, James W. Newman Jr. Roth IRA purchased 10,000 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Shares are held by the James W. Newman Jr. Roth IRA."}],"balance_after":10000,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854717,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":false,"nature":"Virga Ventures LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F12","text":"On July 31, 2018, Virga Ventures LLC purchased 10,000 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"On July 31, 2018, Virga Ventures LLC purchased 10,000 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."}],"balance_after":102000,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854716,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase units","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":92000,"ownership":{"direct":false,"nature":"Virga Ventures LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F10","text":"The warrant to purchase 92,000 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 184,000 shares."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The warrant to purchase 92,000 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 184,000 shares."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F10","text":"The warrant to purchase 92,000 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 184,000 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James W. Newman is the sole member of Virga Ventures, LLC"}],"balance_after":92000,"derivative":{"exercise_price":5,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Units","underlying_shares":184000},"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854715,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase units","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":20000,"ownership":{"direct":false,"nature":"Ivy Cottage Group, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F9","text":"The warrant to purchase 20,000 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 40,000 shares."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The warrant to purchase 20,000 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 40,000 shares."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F9","text":"The warrant to purchase 20,000 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 40,000 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"James W. Newman is the general partner of Ivy Cottage Group, LLC"}],"balance_after":20000,"derivative":{"exercise_price":5,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Units","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854714,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":92000,"ownership":{"direct":false,"nature":"Virga Ventures LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"The 92,000 shares of common stock and warrants to purchase 92,000 shares of common stock were received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The 92,000 shares of common stock and warrants to purchase 92,000 shares of common stock were received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James W. Newman is the sole member of Virga Ventures, LLC"}],"balance_after":92000,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854713,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":20000,"ownership":{"direct":false,"nature":"Ivy Cottage Group, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"The 20,000 shares of common stock and warrants to purchase 20,000 shares of common stock were received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The 20,000 shares of common stock and warrants to purchase 20,000 shares of common stock were received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"James W. Newman is the general partner of Ivy Cottage Group, LLC"}],"balance_after":25178,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854712,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":5178,"ownership":{"direct":false,"nature":"Ivy Cottage Group, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The 5,178 shares of common stock and a warrant to purchase 5,178 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $1,729.95 at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"James W. Newman is the general partner of Ivy Cottage Group, LLC"}],"balance_after":5178,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":5178},"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854711,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":21715,"ownership":{"direct":false,"nature":"Virga Ventures LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The 21,715 shares of common stock and a warrant to purchase 21,715 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $7,255.02 at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James W. Newman is the sole member of Virga Ventures, LLC"}],"balance_after":21715,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":21715},"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854710,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":29931,"ownership":{"direct":false,"nature":"Newman GST Trust FBO James W. Newman Jr."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The 29,931 shares of common stock and a warrant to purchase 29,931 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $10,000 together with accrued interest thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 29,931 shares of common stock and a warrant to purchase 29,931 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $10,000 together with accrued interest thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James W. Newman is the trustee of the Newman GST Trust FBO James W. Neman Jr."}],"balance_after":29931,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":29931},"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854709,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"exercise","acquired":false,"shares":5178,"ownership":{"direct":false,"nature":"Ivy Cottage Group, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The 5,178 shares of common stock and a warrant to purchase 5,178 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $1,729.95 at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The 5,178 shares of common stock and a warrant to purchase 5,178 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $1,729.95 at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The 5,178 shares of common stock and a warrant to purchase 5,178 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $1,729.95 at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"James W. Newman is the general partner of Ivy Cottage Group, LLC"}],"balance_after":0,"derivative":{"exercise_price":0.44,"underlying":"Common Stock","underlying_shares":5178},"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854708,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"exercise","acquired":false,"shares":21715,"ownership":{"direct":false,"nature":"Virga Ventures LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The 21,715 shares of common stock and a warrant to purchase 21,715 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $7,255.02 at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The 21,715 shares of common stock and a warrant to purchase 21,715 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $7,255.02 at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The 21,715 shares of common stock and a warrant to purchase 21,715 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $7,255.02 at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James W. Newman is the sole member of Virga Ventures, LLC"}],"balance_after":0,"derivative":{"exercise_price":0.44,"underlying":"Common Stock","underlying_shares":21715},"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854707,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"exercise","acquired":false,"shares":29931,"ownership":{"direct":false,"nature":"Newman GST Trust FBO James W. Newman Jr."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 29,931 shares of common stock and a warrant to purchase 29,931 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $10,000 together with accrued interest thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The 29,931 shares of common stock and a warrant to purchase 29,931 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $10,000 together with accrued interest thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The 29,931 shares of common stock and a warrant to purchase 29,931 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $10,000 together with accrued interest thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James W. Newman is the trustee of the Newman GST Trust FBO James W. Neman Jr."}],"balance_after":0,"derivative":{"exercise_price":0.44,"underlying":"Common Stock","underlying_shares":29931},"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854706,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F13","text":"On July 31, 2018, James W. Newman Jr. Roth IRA purchased 10,000 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"On July 31, 2018, James W. Newman Jr. Roth IRA purchased 10,000 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Shares are held by the James W. Newman Jr. Roth IRA."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854705,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":false,"nature":"Virga Ventures, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F12","text":"On July 31, 2018, Virga Ventures LLC purchased 10,000 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"On July 31, 2018, Virga Ventures LLC purchased 10,000 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."}],"balance_after":150419,"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854704,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":92000,"ownership":{"direct":false,"nature":"Virga Ventures, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"The 92,000 shares of common stock and warrants to purchase 92,000 shares of common stock were received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The 92,000 shares of common stock and warrants to purchase 92,000 shares of common stock were received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James W. Newman is the sole member of Virga Ventures, LLC"}],"balance_after":140419,"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854703,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":20000,"ownership":{"direct":false,"nature":"Ivy Cottage Group, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"The 20,000 shares of common stock and warrants to purchase 20,000 shares of common stock were received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The 20,000 shares of common stock and warrants to purchase 20,000 shares of common stock were received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"James W. Newman is the general partner of Ivy Cottage Group, LLC"}],"balance_after":35094,"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854702,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":5178,"ownership":{"direct":false,"nature":"Ivy Cottage Group, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The 5,178 shares of common stock and a warrant to purchase 5,178 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $1,729.95 at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The 5,178 shares of common stock and a warrant to purchase 5,178 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $1,729.95 at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"James W. Newman is the general partner of Ivy Cottage Group, LLC"}],"balance_after":15221,"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854701,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":21715,"ownership":{"direct":false,"nature":"Virga Ventures, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The 21,715 shares of common stock and a warrant to purchase 21,715 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $7,255.02 at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The 21,715 shares of common stock and a warrant to purchase 21,715 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $7,255.02 at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James W. Newman is the sole member of Virga Ventures, LLC"}],"balance_after":58419,"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}},{"id":3854700,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":78988,"kind":"person","name":"Newman James W. Jr.","position":1,"cik":"0001718364","reported_name":"Newman James W. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T20:10:35.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":29931,"ownership":{"direct":false,"nature":"Newman GST Trust FBO James W. Newman Jr."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 29,931 shares of common stock and a warrant to purchase 29,931 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $10,000 together with accrued interest thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 29,931 shares of common stock and a warrant to purchase 29,931 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $10,000 together with accrued interest thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James W. Newman is the trustee of the Newman GST Trust FBO James W. Neman Jr."}],"balance_after":41160,"source":{"system":"sec-edgar","filing":"0001213900-18-010089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/ownership.xml","form_type":"4"}}]}